Ainex
Latest round
- Series C
Last raised
- May 2026
Total raised
- $6.7M
Investors
- 4
About Ainex
Based in South Korea, Ainex Corp.Ainex Corp. specializes in AI-powered medical technology, particularly in the field of endoscopy. Founded in 2019, the company is headquartered in Seoul, South Korea. The founder has a background in building tech-focused ventures, although specific past companies are not disclosed. The company has not announced any pivots in its business strategy or operations. Ainex Corporation specializes in AI-powered endoscopy solutions, particularly its core product, ENAD, which facilitates real-time lesion detection and diagnostic support for both upper and lower gastrointestinal (GI) endoscopy. The ENAD system enhances diagnostic accuracy by assisting clinicians in identifying abnormal lesions during procedures such as gastroscopy and colonoscopy, ultimately aiming to improve patient outcomes. With a significant focus on the Korean healthcare market, ENAD is utilized in over 130 hospitals across the country, demonstrating a clear commitment to advancing medical technology in the field of gastroenterology.Ainex Corporation generates revenue through its innovative AI endoscopy solutions, primarily by partnering with hospitals and medical facilities that incorporate ENAD into their diagnostic processes. The company's transactions typically involve direct B2B relationships, where hospitals acquire the software as a medical device for clinical use, thus enhancing their endoscopic capabilities. By providing real-time diagnostic support, ENAD serves as an integral tool in hospitals' offerings, leading to improved operational efficiencies and patient care. Specific pricing plans for the software have not been disclosed; however, the company’s strategy emphasizes fostering long-term partnerships with healthcare providers, potentially involving subscription models or licensing agreements for ongoing software support and updates.
Who invested in Ainex
4 investors across 1 round
See all investors in Ainex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 19, 2026
Amount
$6.7M
Investors
Questions about Ainex
Who invested in Ainex?
Ainex has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ainex raised?
Ainex has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ainex last raise money?
Ainex's most recent round on record is a Series C, in May 2026.
What does Ainex do?
Based in South Korea, Ainex Corp.
Where is Ainex headquartered?
Ainex is headquartered in Seoul, South Korea.
Which VCs invest in companies like Ainex?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Ainex's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like Ainex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.